MELVILLE, N.Y. (PRWEB) | December 01, 2021
DeepRF and Exact RF Handpieces for the VirtueRF Receive FDA-clearance
VirtueRF, the world’s first microneedling platform device, was designed for more versatility than any other RF microneedling technology. Now, providers have even more ways to customize treatments with the FDA-clearance of two new handpieces – DeepRF and ExactRF. The DeepRF and ExactRF handpieces boast 36-needles and 1-needle respectively to treat new areas of the face and body.
VirtueRF launched with the 36-needle SmartRF handpiece which offers clinicians several advancements including robotic precision delivery and unique Sub-Pulse Technology to increase patient comfort without sacrificing power. The two new handpieces will build upon the technology’s sophistication. Like SmartRF, DeepRF offers robotic precision delivery and Sub-Pulse control. DeepRF expands the frequency options and comes with a cooling plate to increase patient comfort. ExactRF adds monopolar radiofrequency to the otherwise bipolar system. The single needle depth can be adjusted for highly precise applications. Furthermore, VirtueRF offers industry leading power at 220 watts.
Cartessa Aesthetics partnered with ShenB, a global leader in RF microneedling manufacturing, to introduce the VirtueRF to the U.S. marketplace. “The demand for RF microneedling is greater than ever and ShenB devices have continued to raise the bar in terms of versatility and patient experience. The expandability of the VirtueRF is a prime example of this,” shared Gabe Lubin, Cartessa Founder and CEO. “With three handpieces, customers can treat more areas and more concerns with a technology they trust. The clinical and financial benefits are substantial.”
DeepRF and ExactRF can easily be added to current VirtueRF platforms. Owners can reserve their new handpieces today and all three handpieces will be options for future VirtueRF purchases. For more information about the VirtueRF, these add-ons and other devices, email info@cartessaaesthetics.com.
